Laporan Keuangan Ringkasan laba rugi, neraca, dan arus kas — KAEF Kimia Farma Tbk.

Emiten
Tahun (s/d)
Periode
Satuan
 
Laba Rugi Neraca Arus Kas
KAEF — Income Statement (Laba Rugi)
Dalam Jutaan IDR  |  Triwulanan  |  9 periode s/d 2026
IDX · Data asli: IDR
Dalam Jutaan IDR Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Total Pendapatan 2,030,6499,223,3287,008,2114,369,3492,168,2089,938,9587,864,2645,213,6952,535,779
Total Beban Pokok Penjualan (1,205,833)(6,159,918)(4,563,132)(2,808,054)(1,425,536)(6,992,485)(5,510,648)(3,634,012)(1,714,942)
Laba Kotor 824,8173,063,4102,445,0801,561,295742,6722,946,4732,353,6161,579,683820,837
Total Beban Usaha (777,826) (3,311,581) (2,407,118) (1,495,825) (763,260) (3,791,000) (2,655,434) (1,745,462) (855,397)
Laba Usaha 46,990(248,171)37,96165,470(20,589)(844,527)(301,818)(165,779)(34,559)
Penghasilan/Beban Lain-Lain 80,965 (189,916) (252,302) (185,480) (106,565) (385,172) (331,838) (192,204) (129,559)
Laba Sebelum Pajak 127,955(438,087)(214,341)(120,010)(127,154)(1,229,699)(633,656)(357,983)(164,119)
Beban Pajak Penghasilan (4,318) (5,271) (19,772) (15,600) 717 21,526 82,813 45,770 22,278
Laba Bersih Dari Operasi Yang Dilanjutkan 123,637(443,357)(234,114)(135,610)(126,437)(1,208,173)(550,844)(312,213)(141,841)
Hak Minoritas ---------
Penyesuaian Proforma ---------
Laba Bersih Tahun Berjalan 123,637(443,357)(234,114)(135,610)(126,437)(1,208,173)(550,844)(312,213)(141,841)
Pendapatan Komprehensif Lain - (251,141) - - - 103,303 4,790 - -
Jumlah Laba Komprehensif 123,637(694,498)(234,114)(135,610)(126,437)(1,104,870)(546,054)(312,213)(141,841)
Laba Bersih Yang Dapat Diatribusikan 123,637 (443,357) (234,114) (135,610) (126,437) (1,208,173) (550,844) (312,213) (141,841)
Laba Komprehensif Yang Dapat Diatribusikan 123,637 (694,498) (234,114) (135,610) (126,437) (1,104,870) (546,054) (312,213) (141,841)
Key Ratios — KAEF ROE, ROA, EPS disetahunkan · Metode Teguh Hidayat · Harga saham: Rp 452 (2026-07-24)
Rasio Q1 2026 ×4 Q4 2025 Q3 2025 ×1⅓ Q2 2025 ×2 Q1 2025 ×4 Q4 2024 Q3 2024 ×1⅓ Q2 2024 ×2 Q1 2024 ×4
Profitabilitas
Gross Margin (%) 40.62% 33.21% 34.89% 35.73% 34.25% 29.65% 29.93% 30.30% 32.37%
Operating Margin (%) 2.31% 2.69% 0.54% 1.50% 0.95% 8.50% 3.84% 3.18% 1.36%
Net Margin (%) 3.67% 3.63% 2.56% 2.17% 4.71% 8.47% 5.36% 4.35% 4.05%
ROE (%) 10.06% 11.61% 7.38% 5.70% 11.75% 24.58% 10.55% 8.23% 7.29%
ROA (%) 2.07% 2.36% 1.61% 1.27% 2.72% 5.63% 3.35% 2.66% 2.37%
Per Lembar Saham
EPS (Rp) 53,50 60,17 43,05 34,14 73,42 151,31 101,04 81,48 73,82
BVPS (Rp) 531,77 518,39 583,30 598,52 625,11 615,59 957,72 990,51 1.013,02
Valuasi
PER (x) 8.45x n/a n/a n/a n/a n/a n/a n/a n/a
PBV (x) 0.85x 0.87x 0.77x 0.76x 0.72x 0.73x 0.47x 0.46x 0.45x
Struktur Modal
DER (x) 4.02x 4.18x 3.67x 3.55x 3.39x 3.37x 1.94x 1.88x 1.84x